Yusuke Tanigawara
- Oncology top 0.5%
- Molecular Biology top 5%
- Pediatrics, Perinatology and Child Health top 0.2%
- Pharmacology top 0.1%
- Pharmacology top 0.5%
- Co-authors
- Terumichi NakagawaKiyoshi YamaokaToyozo UnoKazumitsu UedaTohru KomanoR HoriTakashi SaekiNoboru Okamura
- Topics
- Drug Transport and Resistance Mechanisms (42 papers)Antibiotics Pharmacokinetics and Efficacy (31 papers)Pharmacogenetics and Drug Metabolism (24 papers)
- Cited by
- PharmacologyOncologyTransplantation
- Partner nations
- JapanNew ZealandUnited States
In The Last Decade
Yusuke Tanigawara
173 papers receiving 8.5k citations
Hit Papers
Peers
Comparison fields: 5 of 156
- Oncology 3.9k
- Molecular Biology 2.1k
- Pediatrics, Perinatology and Child Health 1.9k
- Pharmacology 1.5k
- Pharmacology 1.4k
Countries citing papers authored by Yusuke Tanigawara
This map shows the geographic impact of Yusuke Tanigawara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yusuke Tanigawara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yusuke Tanigawara more than expected).
Fields of papers citing papers by Yusuke Tanigawara
This network shows the impact of papers produced by Yusuke Tanigawara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yusuke Tanigawara. The network helps show where Yusuke Tanigawara may publish in the future.
Co-authorship network of co-authors of Yusuke Tanigawara
This figure shows the co-authorship network connecting the top 25 collaborators of Yusuke Tanigawara. A scholar is included among the top collaborators of Yusuke Tanigawara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yusuke Tanigawara. Yusuke Tanigawara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 1 | |
| 4 | 3 | |
| 5 | 3 | |
| 6 | 15 | |
| 7 | 6 | |
| 8 | 6 | |
| 9 | 11 | |
| 10 | Pharmacokinetics of eldecalcitol in primary osteoporosis patients - Randomized, double-blind, multicentre, long-term phase III clinical study | 4 |
| 11 | Overview of the clinical pharmacokinetics of eldecalcitol, a new active vitamin D3 derivative | 13 |
| 12 | Therapeutic drug monitoring survey of anti-MRSA agents in Japan | 4 |
| 13 | 8 | |
| 14 | Population pharmacokinetics and pharmacodynamics of 500 mg oral dose levofloxacin in respiratory tract infection patients | 4 |
| 15 | 2 | |
| 16 | 7 | |
| 17 | Population pharmacokinetics (PK) and pharmacodynamics (PD) of arbekacin in patients infected with methicillin-resistant Staphylococcus aureus (MRSA) | 0 |
| 18 | 1 | |
| 19 | 2 | |
| 20 | 4 |
About Yusuke Tanigawara
Yusuke Tanigawara is a scholar working on Pharmacology, Oncology and Pharmacology, having authored 177 papers that have together received 8.8k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (42 papers), Antibiotics Pharmacokinetics and Efficacy (31 papers) and Pharmacogenetics and Drug Metabolism (24 papers). The work is most often cited by research in Pharmacology (1.5k citations), Oncology (3.9k citations) and Transplantation (324 citations). Yusuke Tanigawara has collaborated with scholars based in Japan, New Zealand and United States. Frequent co-authors include Terumichi Nakagawa, Kiyoshi Yamaoka, Toyozo Uno, Kazumitsu Ueda, Tohru Komano, R Hori, Takashi Saeki, Noboru Okamura, Midori Hirai and Noriyuki Kioka. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.